Joel Finney, etc.,al. Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases. Vaccine, Vol 56, 22 May 2025, 127157. Abstract submitted by kickingbird at 8 hours ago from Vaccine, Vol 56, 22 May 2025, 127157 The discovery of broadly protective antibodies to the influenza virus neuraminidase (NA) has raised interest in NA as a vaccine target. However, recombinant, solubilized tetrameric NA ectodomains are often ... Anika John, etc.,al. [preprint]Wastewater sequencing reveals the genomic landscape of Influenza A virus in Switzerland. https://doi.org/10.1101/2025.04.17.25325990. Abstract submitted by kickingbird at 8 hours ago from https://doi.org/10.1101/2025.04.17.25325990 Influenza A virus poses significant public health challenges, causing seasonal outbreaks and pandemics. Its rapid evolution motivates continuous monitoring of circulating influenza genomes to inform vaccine ... Kang Fang, etc.,al. Detection and prevalence of avian influenza epidemic in the southwest of Poyang Lake and analysis of the influence of meteorological factors. One Health, 2025. Abstract submitted by kickingbird at 8 hours ago from One Health, 2025 Recently, the epidemiological profile of avian influenza has changed dramatically worldwide. Avian influenza sampling and surveillance of wholesale and retail markets in Nanchang, the largest city in the ... Rather, M.A., Hassan, A., Aman, M. et al. Molecular and ecological determinants of mammalian adaptability in avian influenza virus. Infection (2025). Abstract submitted by kickingbird at 8 hours ago from Infection (2025) The avian influenza virus (AIV) primarily affects birds and poses an increasing concern due to its growing adaptability to other hosts, heightening zoonotic risks. The adaptability is a key factor in AIV ... Crofts, K.F., Holbrook, B.C., Page, C.L. et al. Antibody function predicts viral control in newborn monkeys immunised with an influenza virus HA stem nanoparticle. Nat Commun 16, 3785 (2025). Abstract submitted by kickingbird at 8 hours ago from Nat Commun 16, 3785 (2025) The lack of an approved influenza vaccine for infants <6 months, coupled with the requirement for annual updates of current vaccines, warrants the development of a universal vaccine that can confer protection ... | |